Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Cash from Investing Activities (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Cash from Investing Activities for 13 consecutive years, with $588000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 96.25% to $588000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$105.3 million through Dec 2025, down 957.08% year-over-year, with the annual reading at -$105.3 million for FY2025, 957.08% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was $588000.0 at Theravance Biopharma, up from -$100.2 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $1.1 billion in Q4 2022, with the low at -$100.2 million in Q3 2025.
  • Average Cash from Investing Activities over 5 years is $57.6 million, with a median of $4.1 million recorded in 2022.
  • The sharpest move saw Cash from Investing Activities skyrocketed 10379.44% in 2022, then plummeted 82752.38% in 2024.
  • Over 5 years, Cash from Investing Activities stood at $10.8 million in 2021, then surged by 10379.44% to $1.1 billion in 2022, then crashed by 100.06% to -$677000.0 in 2023, then skyrocketed by 2416.99% to $15.7 million in 2024, then crashed by 96.25% to $588000.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $588000.0, -$100.2 million, and -$36.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.